• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导多能干细胞系的建立与组成型 EGFP 报告基因。

Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.

机构信息

Department of Dermatology, University of Colorado School of Medicine, Aurora, CO, USA.

Charles C. Gates Center for Regenerative Medicine, University of Colorado School of Medicine, Aurora, CO, USA.

出版信息

Methods Mol Biol. 2020;2155:11-21. doi: 10.1007/978-1-0716-0655-1_2.

DOI:10.1007/978-1-0716-0655-1_2
PMID:32474864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7396154/
Abstract

The discovery of induced pluripotent stem cell (iPSC) technology has provided a versatile platform for basic science research and regenerative medicine. With the rise of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) systems and the ease at which they can be utilized for gene editing, creating genetically modified iPSCs has never been more advantageous for studying both organism development and potential clinical applications. However, to better understand the behavior and true therapeutic potential of iPSCs and iPSC-derived cells, a tool for labeling and monitoring these cells in vitro and in vivo is needed. Here, we describe a protocol that provides a straightforward method for introducing a stable, highly expressed fluorescent protein into iPSCs using the CRISPR/Cas9 system and a standardized donor vector. The approach involves the integration of the EGFP transgene into the transcriptionally active adeno-associated virus integration site 1 (AAVS1) locus through homology directed repair. The knockin of this transgene results in the generation of iPSC lines with constitutive expression of the EGFP protein that also persists in differentiated iPSCs. These EGFP-labeled iPSC lines are ideal for assessing iPSC differentiation in vitro and evaluating the distribution of iPSC-derived cells in vivo after transplantation into model animals.

摘要

诱导多能干细胞(iPSC)技术的发现为基础科学研究和再生医学提供了一个多功能平台。随着规律成簇间隔短回文重复(CRISPR)/CRISPR 相关蛋白 9(Cas9)系统的兴起,以及它们在基因编辑中的易用性,创建基因修饰的 iPSC 从未如此有利于研究生物发育和潜在的临床应用。然而,为了更好地理解 iPSC 和 iPSC 衍生细胞的行为和真正的治疗潜力,需要一种用于在体外和体内标记和监测这些细胞的工具。在这里,我们描述了一种使用 CRISPR/Cas9 系统和标准化供体载体将稳定、高表达荧光蛋白引入 iPSC 的简单方法。该方法涉及通过同源定向修复将 EGFP 转基因整合到转录活跃的腺相关病毒整合位点 1(AAVS1)位点。该转基因的敲入导致产生持续表达 EGFP 蛋白的 iPSC 系,并且在分化的 iPSC 中也持续存在。这些 EGFP 标记的 iPSC 系非常适合评估体外 iPSC 分化,并评估移植到模型动物后 iPSC 衍生细胞的分布。

相似文献

1
Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.诱导多能干细胞系的建立与组成型 EGFP 报告基因。
Methods Mol Biol. 2020;2155:11-21. doi: 10.1007/978-1-0716-0655-1_2.
2
Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.利用 CRISPR-Cas9 系统对血友病 B 患者来源的诱导多能干细胞进行靶向基因组编辑。
Stem Cell Res Ther. 2018 Apr 6;9(1):92. doi: 10.1186/s13287-018-0839-8.
3
Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives.对AAVS1基因座进行工程改造,以在人诱导多能干细胞及其分化衍生物中实现一致且可扩展的转基因表达。
Methods. 2016 May 15;101:43-55. doi: 10.1016/j.ymeth.2015.12.012. Epub 2015 Dec 18.
4
Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.利用强力霉素诱导型 CRISPR-Cas9 系统对人诱导多能干细胞进行基因编辑。
Methods Mol Biol. 2022;2454:755-773. doi: 10.1007/7651_2021_348.
5
Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers.用于在所有胚层分化细胞中稳定表达转基因的恒河猴诱导多能干细胞安全港基因编辑平台。
Mol Ther. 2017 Jan 4;25(1):44-53. doi: 10.1016/j.ymthe.2016.10.007.
6
Differential Transgene Silencing of Myeloid-Specific Promoters in the Safe Harbor Locus of Induced Pluripotent Stem Cell-Derived Myeloid Cells.诱导多能干细胞源性髓系细胞中安全港位点髓系特异性启动子的差异转基因沉默。
Hum Gene Ther. 2020 Feb;31(3-4):199-210. doi: 10.1089/hum.2019.194. Epub 2020 Jan 23.
7
Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.使用CRISPR/Cas9对人类诱导多能干细胞进行基因编辑和克隆分离
Methods. 2017 May 15;121-122:29-44. doi: 10.1016/j.ymeth.2017.05.009.
8
Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.通过CRISPR/Cas9系统生成的人诱导多能干细胞NEUROG2双敲入报告基因系
Stem Cells Dev. 2015 Dec 15;24(24):2925-42. doi: 10.1089/scd.2015.0131. Epub 2015 Nov 5.
9
Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.开发基于 CRISPR/Cas9 的荧光报告人多能干细胞系用于高通量筛选。
Molecules. 2022 Apr 9;27(8):2434. doi: 10.3390/molecules27082434.
10
CRISPR/Cas-Mediated Knock-in of Genetically Encoded Fluorescent Biosensors into the AAVS1 Locus of Human-Induced Pluripotent Stem Cells.利用 CRISPR/Cas 介导的基因编辑技术将遗传编码的荧光生物传感器敲入人诱导多能干细胞的 AAVS1 基因座。
Methods Mol Biol. 2022;2549:379-398. doi: 10.1007/7651_2021_422.

引用本文的文献

1
CIRCLE-Seq for Interrogation of Off-Target Gene Editing.环状 RNA 测序技术用于探究基因编辑的脱靶效应。
J Vis Exp. 2024 Nov 1(213). doi: 10.3791/67069.

本文引用的文献

1
Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification.尿苷缺失和化学修饰可提高Cas9 mRNA活性并降低免疫原性,无需高效液相色谱纯化。
Mol Ther Nucleic Acids. 2018 Sep 7;12:530-542. doi: 10.1016/j.omtn.2018.06.010. Epub 2018 Jun 30.
2
Delivering CRISPR: a review of the challenges and approaches.递送 CRISPR:挑战与方法综述
Drug Deliv. 2018 Nov;25(1):1234-1257. doi: 10.1080/10717544.2018.1474964.
3
Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization.
利用CRISPR/Cas9对人类干细胞进行系统基因标记以阐明细胞组织。
Mol Biol Cell. 2017 Oct 15;28(21):2854-2874. doi: 10.1091/mbc.E17-03-0209. Epub 2017 Aug 16.
4
CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.利用腺相关病毒供体载体通过CRISPR介导的大基因盒整合
Cell Rep. 2017 Jul 18;20(3):750-756. doi: 10.1016/j.celrep.2017.06.064.
5
Overview of CRISPR-Cas9 Biology.CRISPR-Cas9生物学概述。
Cold Spring Harb Protoc. 2016 Dec 1;2016(12):pdb.top088849. doi: 10.1101/pdb.top088849.
6
RNA-Generated and Gene-Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy.用于疾病建模与治疗的RNA生成及基因编辑诱导多能干细胞
J Cell Physiol. 2017 Jun;232(6):1262-1269. doi: 10.1002/jcp.25597. Epub 2016 Dec 20.
7
Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy.修饰的信使核糖核酸作为质粒脱氧核糖核酸的替代物用于转录替代和疫苗接种治疗。
Expert Opin Biol Ther. 2015;15(9):1337-48. doi: 10.1517/14712598.2015.1057563. Epub 2015 Jun 30.
8
Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application.利用诱导多能干细胞进行疾病建模和细胞治疗:快速安全应用的未来治疗选择。
Blood Res. 2014 Mar;49(1):7-14. doi: 10.5045/br.2014.49.1.7. Epub 2014 Mar 24.
9
RNA-guided human genome engineering via Cas9.通过 Cas9 进行 RNA 引导的人类基因组工程。
Science. 2013 Feb 15;339(6121):823-6. doi: 10.1126/science.1232033. Epub 2013 Jan 3.
10
Safe harbours for the integration of new DNA in the human genome.人类基因组中新 DNA 整合的安全港。
Nat Rev Cancer. 2011 Dec 1;12(1):51-8. doi: 10.1038/nrc3179.